AI-generated summary
This open-label phase IIa study in three centers evaluated hemoporfin photodynamic therapy with a 532 nm continuous laser for port-wine stain at three laser exposure times. The authors report response rates of 80.0% and 94.7% in the first two groups, with similar adverse event rates and self-limiting photosensitive dermatitis and hyperpigmentation as the most common events. The third stage was cancelled for patient safety.
- Participants
- 40
- Who or what was studied
- Patients with port-wine stain aged 16 to 50 years
- Wavelengths
- 532 nm
- Limits stated in the abstract
- The abstract describes an open-labeled study without a control group, and the third stage was cancelled, limiting the comparisons possible.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 532 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.